Last Updated : November 21, 2019
Today, CADTH has issued final recommendations for:
teduglutide (Revestive)
Indications: Short Bowel Syndrome (SBS), pediatrics
Recommendation: Reimburse with clinical criteria and/or conditions
Last Updated : November 21, 2019